SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technical analysis for shorts & longs
SPY 665.67-0.9%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clint E. who wrote (15921)5/10/1998 11:51:00 AM
From: aknahow  Read Replies (1) of 68069
 
Read the Barrons cover story on duPont. One of its' expressed alternatives is acquisition of a small biotech. TSC or thestreet.com recently ran article on German interest in U.S. drug stocks, not clear if this also means biotechs. Todays Sunday N.Y. Times jumps on Jim Cramers concept, without any mention of the TSC, with article giving historical past acquisition and indicating more to come.

The biotech sector is IMO in play. See XOMA thread for longer thoughts on implication of the article. This is a sector thing, not a XOMA specific event. Posted there only because I did not know where else to post it. I think the article will impact your list of stocks. Let me know if see any sector or list specific move.

Believe we will see over-valuations as well as breakouts as the implications of the article are realized.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext